| Serial Number | 99368321 |
| Word Mark | GENEPGX |
| Filing Date | Monday, September 1, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, February 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific study and research in the field(s) of biotechnology; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation |
| Pseudo Mark | GENE PGX |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 1, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, November 30, 2022 |
| First Use In Commerce Date | Wednesday, November 30, 2022 |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Chicago, IL 60607 |
| Event Date | Event Description |
| Monday, September 1, 2025 | NEW APPLICATION ENTERED |
| Monday, September 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 21, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 22, 2026 | ASSIGNED TO EXAMINER |
| Friday, January 23, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, January 23, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, January 23, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 2, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 2, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 2, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |